Latest News from: Corewell Health

Filters close
Released: 9-Sep-2024 11:05 AM EDT
While Vaccines Target the Changing Parts of Coronavirus, Researchers Suggest It’s the Unchanging Parts We Also Need to Pay Attention to
Corewell Health

For the past three years, Corewell Health researchers have been studying the genetic code of the virus that causes COVID-19 to better understand how it is changing and how to avoid another pandemic. Much of the world’s focus has been on the development of vaccines to prevent the spread of the virus; however, vaccines primarily target the portion of the virus that constantly changes, requiring vaccines to be regularly updated.

9-Aug-2024 4:00 PM EDT
Mild cognitive impairment could be going unreported in rural areas of West Michigan, study suggests
Corewell Health

Corewell Health™ and Michigan State University researchers are the first in the state to use de-identified electronic health records of more than 1.5 million patients to analyze incidence rates and risk factors of mild cognitive impairment, or MCI, in rural and urban areas in West Michigan.

Newswise: Study suggests an MRI may help doctors predict more aggressive prostate cancer in patients
Released: 7-Aug-2024 8:00 AM EDT
Study suggests an MRI may help doctors predict more aggressive prostate cancer in patients
Corewell Health

New Corewell Health™ research suggests an MRI scan can help predict whether patients with intermediate-risk prostate cancer (cancer confined to the entire prostate) may have more aggressive cancer in five years.

Released: 15-Jul-2024 8:05 PM EDT
Participate in Study to Reduce Disparate Growth of Alzheimer’s Disease in Black Population
Corewell Health

Corewell Health is working with Johns Hopkins Bloomberg School of Public Health and North Carolina Agricultural and Technical State University to learn more about the multi-level risk and biopsychosocial factors that contribute to Alzheimer’s disease in Black Americans, leading to the development of effective, tailored behavioral and pharmacological interventions aimed at reducing the condition’s disparate attack.



close
0.12925